• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受乳腺癌化疗的韩国女性的认知缺陷。

Cognitive deficits in Korean women treated with chemotherapy for breast cancer.

作者信息

Jung Mi Sook, Cimprich Bernadine

机构信息

Author Affiliations: School of Nursing, University of Michigan, Ann Arbor.

出版信息

Cancer Nurs. 2014 May-Jun;37(3):E31-42. doi: 10.1097/NCC.0b013e3182980383.

DOI:10.1097/NCC.0b013e3182980383
PMID:23945143
Abstract

BACKGROUND

Cognitive deficits have been reported as detrimental side effects in chemotherapy-treated breast cancer patients and survivors. Korean women treated for breast cancer may experience unrecognized cognitive deficits related to their treatment. However, no research has examined cognitive test performance in chemotherapy-treated Korean breast cancer survivors.

OBJECTIVE

The objectives of this study were 2-fold: (1) to examine differences in occurrence and severity of cognitive deficits in Korean women treated with adjuvant chemotherapy for breast cancer as compared with a control group of women without breast cancer and (2) to examine the relationship of selected demographic and cultural factors with cognitive test performance.

METHODS

Sixty-four Korean women, 32 women treated for localized breast cancer and 32 healthy controls, were enrolled. Breast cancer participants were assessed with established cognitive measures within 4 months after chemotherapy, and healthy controls, within 6 months after negative screening mammography.

RESULTS

The breast cancer group showed a significantly higher occurrence and greater severity of cognitive deficits than controls did. Importantly, older age, less education, greater collectivist tendency, and greater childrearing burden were reliably associated with poorer attention and working memory test performance.

CONCLUSIONS

Cognitive deficits were found in chemotherapy-treated Korean women with moderate to large effect sizes compared with controls. Cultural characteristics contributed to worse cognitive performance.

IMPLICATIONS FOR PRACTICE

Healthcare providers should recognize that Korean women may be highly vulnerable to cognitive deficits. Cultural factors also need to be considered when assessing cognitive function and designing therapeutic interventions to counteract negative cognitive outcomes.

摘要

背景

认知缺陷已被报道为接受化疗的乳腺癌患者及其幸存者的有害副作用。接受乳腺癌治疗的韩国女性可能存在与治疗相关但未被识别的认知缺陷。然而,尚无研究考察接受化疗的韩国乳腺癌幸存者的认知测试表现。

目的

本研究的目的有两个:(1)考察接受辅助化疗的韩国乳腺癌女性与未患乳腺癌的女性对照组相比,认知缺陷的发生率和严重程度的差异;(2)考察选定的人口统计学和文化因素与认知测试表现之间的关系。

方法

招募了64名韩国女性,其中32名接受局部乳腺癌治疗的女性和32名健康对照者。乳腺癌参与者在化疗后4个月内采用既定的认知测量方法进行评估,健康对照者在乳腺钼靶筛查阴性后6个月内进行评估。

结果

乳腺癌组的认知缺陷发生率和严重程度显著高于对照组。重要的是,年龄较大、受教育程度较低、集体主义倾向较强以及育儿负担较重与注意力和工作记忆测试表现较差可靠相关。

结论

与对照组相比,接受化疗的韩国女性存在认知缺陷,效应量为中度至重度。文化特征导致认知表现更差。

对实践的启示

医疗保健提供者应认识到韩国女性可能极易出现认知缺陷。在评估认知功能和设计治疗干预措施以应对负面认知结果时,也需要考虑文化因素。

相似文献

1
Cognitive deficits in Korean women treated with chemotherapy for breast cancer.接受乳腺癌化疗的韩国女性的认知缺陷。
Cancer Nurs. 2014 May-Jun;37(3):E31-42. doi: 10.1097/NCC.0b013e3182980383.
2
Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.乳腺癌辅助化疗 20 多年后幸存者的神经心理学表现。
J Clin Oncol. 2012 Apr 1;30(10):1080-6. doi: 10.1200/JCO.2011.37.0189. Epub 2012 Feb 27.
3
The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.标准辅助化疗与大剂量化疗后乳腺癌幸存者的神经心理损伤、自我认知的认知缺陷、疲劳及健康相关生活质量之间的关联。
Patient Educ Couns. 2007 Apr;66(1):108-18. doi: 10.1016/j.pec.2006.11.005. Epub 2007 Feb 21.
4
The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.乳腺癌女性辅助化疗相关认知障碍的性质和严重程度:当前文献的荟萃分析
Brain Cogn. 2005 Oct;59(1):60-70. doi: 10.1016/j.bandc.2005.05.001. Epub 2005 Jun 21.
5
Selective impairment of attention networks in breast cancer patients receiving chemotherapy treatment.接受化疗的乳腺癌患者注意力网络的选择性损伤。
Psychooncology. 2014 Oct;23(10):1165-71. doi: 10.1002/pon.3539. Epub 2014 Apr 15.
6
Dissociation of decision making under ambiguity and decision making under risk in breast cancer patients receiving adjuvant chemotherapy: a neuropsychological study.在接受辅助化疗的乳腺癌患者中,对模糊情境下的决策与风险决策的分离:一项神经心理学研究。
Brain Res. 2013 Oct 2;1533:63-72. doi: 10.1016/j.brainres.2013.08.015. Epub 2013 Aug 14.
7
Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: 'subjective' complaints and 'objective' neuropsychological test results.认知缺陷作为乳腺癌患者辅助治疗的长期副作用:“主观”主诉和“客观”神经心理学测试结果
Psychooncology. 2009 Jul;18(7):775-82. doi: 10.1002/pon.1472.
8
Cognitive effects of chemotherapy in breast cancer patients: a dose-response study.化疗对乳腺癌患者认知功能的影响:一项剂量反应研究。
Psychooncology. 2013 Jul;22(7):1517-27. doi: 10.1002/pon.3163. Epub 2012 Aug 30.
9
Analysis of memory deficits following chemotherapy in breast cancer survivors: evidence from the doors and people test.乳腺癌幸存者化疗后记忆缺陷分析:来自门和人测试的证据。
J Psychosoc Oncol. 2011;29(5):499-514. doi: 10.1080/07347332.2011.600751.
10
Neurotoxic Effects of Anthracycline- vs Nonanthracycline-Based Chemotherapy on Cognition in Breast Cancer Survivors.蒽环类与非蒽环类化疗药物对乳腺癌幸存者认知功能的神经毒性作用。
JAMA Oncol. 2016 Feb;2(2):185-92. doi: 10.1001/jamaoncol.2015.4333.

引用本文的文献

1
Cancer-related cognitive impairment in racial and ethnic minority groups: a scoping review.癌症相关认知障碍在少数族裔群体中的研究:范围综述。
J Cancer Res Clin Oncol. 2023 Oct;149(13):12561-12587. doi: 10.1007/s00432-023-05088-0. Epub 2023 Jul 11.
2
Prevalence of cognitive impairment following chemotherapy treatment for breast cancer: a systematic review and meta-analysis.化疗治疗乳腺癌后认知障碍的患病率:系统评价和荟萃分析。
Sci Rep. 2022 Feb 8;12(1):2135. doi: 10.1038/s41598-022-05682-1.
3
Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events.
化疗诱导认知功能障碍的四十年:临床、动物和体外研究的综合回顾,以及关键起始事件的见解。
Arch Toxicol. 2022 Jan;96(1):11-78. doi: 10.1007/s00204-021-03171-4. Epub 2021 Nov 2.
4
Clinical impact of melatonin on breast cancer patients undergoing chemotherapy; effects on cognition, sleep and depressive symptoms: A randomized, double-blind, placebo-controlled trial.褪黑素对接受化疗的乳腺癌患者的临床影响;对认知、睡眠和抑郁症状的影响:一项随机、双盲、安慰剂对照试验。
PLoS One. 2020 Apr 17;15(4):e0231379. doi: 10.1371/journal.pone.0231379. eCollection 2020.
5
Quality of Life of Women After a First Diagnosis of Breast Cancer Using a Self-Management Support mHealth App in Taiwan: Randomized Controlled Trial.台湾地区首次诊断乳腺癌后使用自我管理支持型移动医疗应用的女性生活质量:随机对照试验。
JMIR Mhealth Uhealth. 2020 Mar 4;8(3):e17084. doi: 10.2196/17084.
6
Cognitive Effects of Cancer and Cancer Treatments.癌症与癌症治疗的认知影响。
Annu Rev Clin Psychol. 2018 May 7;14:425-451. doi: 10.1146/annurev-clinpsy-050817-084903. Epub 2018 Jan 18.
7
Post-treatment cognitive dysfunction in women treated with thyroidectomy for papillary thyroid carcinoma.甲状腺乳头状癌甲状腺切除术后女性的治疗后认知功能障碍
Support Care Cancer. 2017 Mar;25(3):915-923. doi: 10.1007/s00520-016-3481-y. Epub 2016 Nov 11.
8
Assessment of Cognitive Impairment and Complaints in Individuals With Colorectal Cancer.结直肠癌患者认知障碍及主诉的评估
Oncol Nurs Forum. 2016 Mar;43(2):169-78. doi: 10.1188/16.ONF.43-02AP.